SCHEMBL4845331

SCHEMBL4845331

Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@]1(O)F

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.64
NT5E P21589 2/20 0.64
HIF1A Q16665 1/20 0.64
ADORA2A P29274 5/20 0.60
ADA P00813 1/20 0.55
AHCY P23526 4/20 0.53
CA5A P35218 1/20 0.48
ADORA3 P0DMS8 2/20 0.47
ADORA1 P30542 2/20 0.47
PDE4D Q08499 2/20 0.47
PDE3A Q14432 2/20 0.47
PDE2A O00408 1/20 0.47
ADRA1A P35348 1/20 0.47
ADORA2B P29275 2/20 0.47
PNP P00491 1/20 0.46
TP53 P04637 1/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1888832 0.90 ADORA2A (0.61) LMNANT5EHIF1AADORA2AADA
SCHEMBL4839727 0.90 ADORA2A (0.61) LMNANT5EHIF1AADORA2AADA
SCHEMBL3929236 0.88 ADORA2A (0.77) LMNANT5EHIF1AADORA2AADA
SCHEMBL6399921 0.88 ADORA2A (0.77) LMNANT5EHIF1AADORA2AADA
SCHEMBL29135436 0.88 ADORA2A (0.77) LMNANT5EHIF1AADORA2AADA
SCHEMBL19859343 0.85 LMNA (0.60) LMNANT5EHIF1AADORA2AADA
SCHEMBL546108 0.84 ADORA2A (0.76) HIF1AADORA2AADAAHCYADORA3
SCHEMBL4845625 0.84 ADORA2A (0.76) HIF1AADORA2AADAAHCYADORA3
SCHEMBL18561719 0.84 CA5A (0.69) LMNANT5EHIF1AAHCYCA5A
SCHEMBL4835994 0.81 ADORA2A (0.56) LMNANT5EHIF1AADORA2AADA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7381820-B2 α-1-phosphorylated-2-deoxy-2-fluoroarabinoside and process for producing 2′-deoxy-2′-fluoro-β-d-arabinonucleoside YAMASA CORPORATION (JP) 2008-06-03 US disclosed
US-20070135627-A1 Alpha-1-phosphorylated-2-deoxy-2-fluoroarabinoside and process for producing 2'-deoxy-2'-fluoro-beta-d-arabinonucleoside KOHEL YAMADA, ETAL 2007-06-14 US disclosed
EP-1676853-A1 ALPHA-1-PHOSPHORYLATED-2-DEOXY-2-FLUOROARABINOSIDE AND PROCESS FOR PRODUCING 2 -DEOXY-2 -FLUORO-BETA-D-ARABINONUCLEOSID E YAMASA CORPORATION (JP) 2006-07-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135627-A1 Alpha-1-phosphorylated-2-deoxy-2-fluoroarabinoside and process for producing 2'-deoxy-2'-fluoro-beta-d-arabinonucleoside TYMP, PNP, DUT LMNA 2519/4885NT5E 192/4885HIF1A 1313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.